Colorado Wholesale Cannabis Price-Per-Pound Has Dropped 25 percent

a word from our sponsors:

advertisement

advertise here

The wholesale cost of Colorado’s legal cannabis per pound has dropped 25 percent over the last year, according to state Department of Revenue figures outlined by Inc. Geoff Doran, co-founder of Tradiv, an online cannabis wholesaler, said that the average price per pound in Colorado – currently $1,200 – is down from $1,900 in 2016, and from $2,600 in 2015.

Sally Vander Veer, co-founder of Medicine Man, a licensed Colorado cultivator and retailer, said that in 2010 the company would have been able to secure per pound rates of about $5,000. She indicated that flower margins have dropped by as much as 40 percent.

The decline doesn’t come as a surprise Vander Veer, who predicts that the drop off will force many cultivators out of business over the next 18 months if they fail to adapt to the changing market.

“It’s sad, but it’s Economics 101, we’re not immune to the forces of supply and demand. You need to ride the wave of over-supply,” she said in the report. “It’s pivot, or die.”

After researching data in Washington, Steve Davenport, a Pardee RAND graduate school researcher, and Jonathan Caulkins, a professor at Carnegie Mellon University, predicted that the price of cannabis would drop 2 percent each month, representing an annual decrease of 24 percent.

“It’s just a plant,” Caulkins said in a May 2016 interview with the Washington Post. “There will always be the marijuana equivalent of organically grown specialty crops sold at premium prices to yuppies, but at the same time, no-frills generic forms could become cheap enough to give away as a loss leader – the way bars give patrons beer nuts and hotels leave chocolates on your pillow.”

End


Limited MMJ Bill Introduced in Nebraska Despite Electoral Defeat of Longtime Champion

a word from our sponsors:

advertisement

advertise here

Freshman Nebraska State Sen. Anna Wishart has introduced medical cannabis legislation, continuing the work of former Sen. Tommy Garrett who was not reelected, KMTV reports.  The bill, which faces opposition in the state from law enforcement agencies and Republican Gov. Pete Ricketts, is of the limited variety – permitting oil and pill cannabis treatments for less than 25 serious or chronic conditions.

According to the bill text, the measure would allow one “registered manufacturer” and four dispensaries in each of the state’s congressional districts and provides for independent laboratory testing. It also includes language that allows attorneys to work with the industry – an issue that often must be taken up by state Bar Associations or courts after legislation is passed.

Obtaining and keeping state-approved cannabis licenses would be costly under the regime, which calls for an annual fee “not to exceed” $75,000 for manufacturers and $25,000 for compassionate care centers and dispensaries.

A Medical Cannabis Board would be created and tasked with regulating the industry and adding to the qualifying condition list. The seven-member board would consist of five legislature-approved governor-appointees from each congressional district. Under the requirements, at least one member would be licensed pharmacist, and at least one would be “licensed to practice medicine and surgery.”

If passed, the law would take effect on July 1, 2018.

End


New York MMJ Revenues Well Below Administration’s Expectations

a word from our sponsors:

advertisement

advertise here

New York’s medical cannabis tax revenues are far less than anticipated as officials are expecting just $1 million after budgeting for $4 million when the program was announced, Politico reports. The revenues, which officials do not expect to grow over the next three years, come from a 7 percent excise tax on medical cannabis sales.

The first full year of the state’s limited medical cannabis program has experienced growing pains. In August, three of the state’s five licensed producers indicated they were still not profitable; at that time PharmaCann representative estimated that it would be another 18 months before they moved into the black. Last week one of those five companies, New York City operator Bloomfield Industries, was purchased by California-based MedMen. According to a previous Politico report, Bloomfield was experiencing “financial constraints.”

However, the state Health Department did expand access to the program by adding chronic pain to the qualifying condition list, and allowing physician assistants and nurse practitioners to certify patients for medical cannabis use.

According to Department of Health data, there are currently 12,530 registered patients and 824 registered practitioners under the program, up from the 10,730 patients and 750 practitioners counted in the agency’s two-year report released in December.

End


Green Man Plans to Renovate Grow Facility ‘To the Studs’ Following Product Recall

a word from our sponsors:

advertisement

advertise here

Denver’s Green Man Cannabis has issued a voluntary recall of some of its cannabis flower and edible products over concerns that it contains residual levels of illegal, off-label pesticides, the Denver Department of Environmental Health said in a recall notice.

The department is urging customers who purchased the affected products from Green Man shops on Santa Fe Drive and Hampden Avenue locations to return them to the location they purchased them from or dispose of them.

In a press release, Christian Hageseth, Green Man CEO, said the company believes “the plants became compromised from pesticide residue in the building, not application” and they are “taking the most aggressive steps possible to correct this.”

“We are now convinced residues remained, unknown to us, in the building’s duct work, paint, and flooring, and circulating air tainted the plants,” he said. “…Our plan is to rip out everything in our grow facilities – take it down to the studs.”

Hageseth indicated that the retail shops would remain open and would sell products from other growers “until we are confident that no pesticide residue is present.”

According to the health department website, more than 30 cannabis recalls have been issued since July 2015, 14 of which occurred last year. There have been no reports of illness related to the Green Man recall.

End


Children raising their hands during a school assembly.

Bill Filed to Allow Students to Consume Cannabis at School in Washington State

a word from our sponsors:

advertisement

advertise here

One of the major concerns around cannabis has always been youth access. However, like adults, some kids need cannabis products to help them live normal, healthy lives.

All but nine states have now softened their stance on either medical cannabis or high CBD cannabis products specifically to help children suffering from epilepsy. These advances in MMJ reform have brought up interesting questions around kids and cannabis — the least of which is how to safely administer cannabis to kids at school.

It is illegal to bring cannabis onto a school campus in Washington state. A new bill filed in the 2017 session seeks to change that and treat cannabis like other prescribed medicines. HB 1060, a.k.a. Maddie & Ducky’s Law, will allow parents, guardians, or caregivers to administer oral cannabis to students at school, on a school bus, or at school-sponsored events.

Meagan Holt, whose daughter Maddie uses cannabis to treat her Zellweger syndrome said, “Maddie & Ducky’s Law would allow medically complex children, like Maddie, to safely access an education. Schools already have policies around safe use of other controlled substances. All we are asking is that cannabis be included in those policies because, for kids like Madeline, cannabis is a life-saving medication that she can not go without.”

Holt said she’s been humbled by the support the 3-page bill has garnered in Olympia and is optimistic about it passing this session.

End


German Parliament Unanimously Approves National MMJ Legislation

a word from our sponsors:

advertisement

advertise here

Germany’s parliament has voted unanimously to legalize medicinal cannabis use, paving the way for patients with a doctor’s prescription to purchase the drug from pharmacies, Deutsche Welle reports. The measure was strongly supported by Marlene Mortler, a member of the conservative Christian Social Union and the nation’s drug commissioner.

“It’s a great addition for patients who have waited for this a long time,” she said in the DW report.

According to a report from The Local, the new law will expand the country’s current medical cannabis program, which allowed only people with serious medical conditions to use cannabis for self-therapy. Only about 1,000 people were permitted to use the drug under the current regime. Eventually, rules and regulations will be in place allowing cannabis to be grown under the supervision of the state. Private companies will also be considered for cultivation and processing approval, but the requirements will likely be strict.

Under the law, expected to be implemented in March, cannabis therapies will be covered by health insurers when necessary.

“Cannabis as a medicine is certainly not a miracle drug,” Mortler told The Local. “But everyone should have the right to have it paid for when it helps.”

End


Legal and Illegal North American Cannabis Sales Outpace Starbucks, McDonald’s in 2016

a word from our sponsors:

advertisement

advertise here

Total combined sales for legal and illegal cannabis sales in North America reached $53.3 billion last year, more than Starbucks and McDonald’s combined, according to Arcview Market Research figures outlined by Business Insider. Illegal sales made up 87 percent of total cannabis sales in 2016, down from 90 percent the year prior. The legal market gained 30 percent from 2015, earning $6.7 billion in North America last year.

Troy Dayton, Arcview Market Research CEO, explained that unlike other consumer industries the cannabis market “doesn’t need to create demand” for new products “it just needs to move demand for an already widely-popular product into legal channels.”

“The enormous amount of existing, if illicit, consumer spending sets cannabis apart from most other major consumer-market investment opportunities throughout history,” Dayton said in the report.

Yet, despite not needing to create demand, the legal cannabis industry is full of product innovations – such as edibles, topicals, and sprays – which, in Colorado made up 45 percent of total legal sales in the third quarter of 2016. In the first quarter of 2014, those products represented 30 percent of the state’s legal sales. Dayton said that “variety” is “one of the major reasons” people move to legal markets in states where it’s permitted.

End


California Community College Planning to Offer Legal Cannabis Course

a word from our sponsors:

advertisement

advertise here

California’s City College of San Francisco is partnering with the United Food and Commercial Workers union and Oakland-based Oaksterdam University to develop a new course aimed at the legal cannabis industry, according to a report from the San Francisco Examiner

The course for the two-year community college has yet to be developed but it will likely focus on production and distribution. School officials have not decided whether it would be available to all students or offered exclusively through an agreement between the college’s Pharmacology Technology department and the union. However, according to college spokesman Jeff Hamilton “at the moment” enrollees would need to be sponsored by the UFCW or another union with apprenticeship programs, such as the Laborers’ Local 261’s Gardener Apprenticeship Program.

“Obviously, with the potential growth of this industry being substantial, particularly in California, we want to offer access to this growing industry,” Hamilton said in the report, explaining that Oaksterdam faculty would be used due to their “expertise” in the industry.

Dale Sky Jones, executive chancellor for Oaksterdamn University, said that she would prefer that the training not be limited to union members, noting that “things still need to be sussed out.”

“I just want to make sure the training is available for as much people as possible,” she said.

The college, which recently had its accreditation affirmed for seven years after it was revoked three years ago, plans on rolling out the course in the spring 2018 semester.

End


Denver Workgroup Begins Drafting Social-Use Rules

a word from our sponsors:

advertisement

advertise here

Stakeholders in Denver, Colorado have begun working on rule suggestions for the voter-approved social use measure, which will allow cannabis to be consumed by adults 21 and older in places that do not hold liquor licenses, according to an Associated Press report. The workgroup, made up of city regulators, business owners, and measure opponents started drafting the rules on Wednesday.

Emmett Reistroffer, a cannabis industry consultant who ran the social-use campaign, indicated that the regulations will likely require neighborhood approval before any business is given a license but said “there are plenty of places in Denver where you can find neighbors who want this kind of establishment.”

There is no deadline for the city to finalize the rules, and the measure does not allow businesses with social-use licenses to sell cannabis – meaning customers would bring their own products. Smoked products would still need to be used outdoors.

Rachel O’Bryan, the opposition organizer, said she was concerned that because the businesses have no control over what is consumed they won’t be able to safeguard against intoxicated driving.

“If you are neither serving nor counting the potency of the product, nor counting how much they consume, how are you protecting the public when they leave your property?” she asked.

A bill to allow social-use statewide is currently in the state Legislature.

End


Obama Commutes Hundreds of Federal Drug Sentences

a word from our sponsors:

advertisement

advertise here

With his term ending in just two days, President Barack Obama has commuted hundreds more federal drug sentences for those convicted under the mandatory minimum sentences laws of the 1980s and 1990s, according to a Washington Post report. So far, commutations under the Democratic president have reached 1,176 – more than 400 of which were life sentences – but his office has not specified the number under the latest round.

Deputy Attorney General Sally Q. Yates said that the personnel working on the case “killed themselves” to get the final recommendations to the president and that U.S. Pardon Attorney Robert A. Zauzmer has not taken a day off since he was brought on in February to help sift through the backlog.

“We were in overdrive,” Yates, who led the clemency initiative, said in the report. “We were determined to live up to our commitment. It was 24-7 over the Christmas break.”

Three years ago then-Attorney General Eric Holder adopted a policy that reserved the most severe penalties for high-level or violent drug offenders, rather than impose mandatory minimums on low-level and non-violent drug offenders.

However, just because an inmate is granted clemency does not mean they will be immediately released. In many cases inmates will see their sentences significantly reduced; in some cases the offender will remain in prison for years.

It’s unclear, but highly unlikely, whether President-elect Donald Trump will continue Obama’s clemency initiative. On the campaign trail, Trump criticized the program while praising private prisons. His attorney general-nominee, Republican Sen. Jeff Sessions, is a hardline prohibitionist and during a 2010 Senate Judiciary Hearing said he thinks “there is a role for private prisons in the American system.”

Trump will take office on Jan. 20.

End


Adult-Use Bill Filed in New Mexico

a word from our sponsors:

advertisement

advertise here

Two Democratic New Mexico state Representatives have pre-filed legislation that would legalize adult-use cannabis in the state, setting up a system of licensing and taxes. The bill is sponsored by Representatives Bill McCamley and Javier Martínez.

According to the bill text, the Cannabis Revenue and Freedom Act would allow personal possession of 1 ounce of cannabis in public, two inside a person’s home, and up to 7 grams of concentrates. It provides home grow provisions for up to six plants per-person, so long as the number of plants grown in one residence does not exceed 12 and the total amount of cannabis on-hand from home grows does not exceed 8 ounces. The bill also permits for in-home processing, with caps set at 16 ounces of concentrates in “solid form,” and 72 ounces in “liquid form.”

“The purpose of the Cannabis Revenue and Freedom Act is…to eliminate problems caused by the prohibition and uncontrolled manufacture, possession and delivery of marijuana within New Mexico; [and] to protect the peace, health, safety and welfare of the people of this state by prioritizing the state’s limited law enforcement resources in the most effective way,” the bill states.

An 11-member governor-appointed Cannabis Control Board would be created, and would include two members licensed under the act, two medical or health professionals, one patient, one member of the public, one banking or financing professional, one member of the regulation and licensing department, and one member each from the state Agriculture, Health, and Environment departments.

A portion of the funds raised from the state’s cannabis tax – set at 15 percent statewide allowing for another 5 percent levied by individual municipalities and counties – would be used to subsidize medical cannabis for low-income patients.

End


Wisconsin Democrats Hoping to Introduce MMJ Expansion Bill

a word from our sponsors:

advertisement

advertise here

Democrats in Wisconsin are seeking co-sponsors for a comprehensive medical cannabis bill with plans to introduce the legislation this session, the Associated Press reports. The move comes after Republican Assembly Speaker Robin Vos indicated he would be open to supporting such a measure.

Currently, only CBD use is allowed under the state’s limited medical cannabis program and the regime does not permit growing cannabis within the state which limits access to the drug. Federal law prohibits any cannabis product, including CBD, to be transported across state lines, preventing patients and caregivers in Wisconsin from legally obtaining medicines from nearby states with looser laws.

State Sen. Jon Erpenbach and Rep. Chris Taylor have sent a letter to their respective colleagues asking for their support of the bill, explaining that the public supports medicinal cannabis use and the program would help people suffering with chronic and debilitating illnesses.

However, the proposal would face opposition from Republican Gov. Scott Walker and in the Senate from Republican Majority Leader Scott Fitzgerald. Republicans control both the Senate and Assembly, so even if a bill were introduced it would be up to them whether or not to send the bill to committee or hold a hearing on the plan.

End


Cresa Pharma Nets EU Approval to Sell CBD Pet Products

a word from our sponsors:

advertisement

advertise here

Creso Pharma, publicly traded on the Australian Securities Exchange, has received registration from the European Union – the first – to sell CBD products for pets, according to an Australian Associated Press report. The company is now seeking a global import and export license as it’s planning to market two products by April.

The products are designed to help treat chronic pain, arthritis, diabetes, and behavioral disorders, including anxiety and noise phobias.

Creso CEO and Co-Founder Miri Halperin Wernli said that many products currently available in the cannabis-for-pets market are “human-based medicines that have been poorly adapted for animals.”

“Our unique CBD-based nutraceutical products are developed specifically for companion animals and are an alternative therapeutic option to a number of common medical conditions among pets that often remain poorly treated,” she said in the report.

Stephane Ready, Creso Pharma Australia pharmaceutical consultant, said the EU registration helps guarantee the purity profile, quality and accuracy of the company’s pet products.

“The industry is changing fast, regulations are changing fast it is very important that the high standards are applied,” he said. “The seal of approval is much more comforting and pleasing than a product sold over the internet.”

Following the announcement, Creso shares gained 11.9 percent, or 2.5 cents, raising its share price to 23.5 cents.

End


Minnesota Medical Solutions Employees Ratify New Union Contract

a word from our sponsors:

advertisement

advertise here

Minnesota Medical Solutions employees, represented by the United Food and Commercial Workers Union Local 1189, have ratified a new three-year union contract which includes a wage increase and an agreement that the employer will cover the recent increase in health insurance costs. Minnesota Medical Solutions is owned by Vireo Health.

Jennifer Christensen, Local 1189 president, called the deal “a fair settlement” that ensures the company’s ability to “recruit and retain exceptional workers.”

“What is really important is the employer’s commitment to full-time living wage union jobs.  Part-time jobs do exist but as business expands and hours become available those jobs are transformed into full-time,” she said in a press release announcing the deal. “Minnesota Medical Solutions is leading the way nationally, and it shows in the quality of products and services that our members provide for the people of Minnesota.”

In addition to the wage increase and healthcare coverage, the agreement includes additional pay for new lead positions, training premiums, progression increases, paid time off, mileage and travel time reimbursements, and holiday pay increases.

Vireo Health of New York employees ratified their own union contract – the first in the state – with the Local 338 of the Retail, Wholesale, and Department Store Union, UFCW in November.

End


Brazil Healthcare Regulator Signs Off on Sativex Sales

a word from our sponsors:

advertisement

advertise here

Brazilian healthcare regulator ANVISA has issued the nation’s first license for the sale of a cannabis-based drug as São Paulo-based Beaufour Ipsen Farmacêutica Ltda has been given the green light to distribute the oral spray Sativex, according to a Reuters report.

The product, used to treat multiple sclerosis, is developed by British pharmaceutical firm GW Pharmaceuticals PLC ad will be sold under the brand name Mevatyl in the South American country. The drug is already available in 28 other countries.

Following several court cases by patients attempting to receive medical cannabis treatment in Brazil, ANVISA has relaxed their rules over the last two years, allowing some patients to personally import cannabis-derived drugs. ANVISA has allowed case-by-case importation of Medical Marijuana, Inc.’s Real Scientific Hemp Oil product for treating cancer and Parkinson’s disease. The cost of the RSHO is subsidized under the federal government healthcare system. In 2015 the Brazilian National Health Surveillance Agency reclassified CBD as “controlled” rather than illegal, authorizing its use as a treatment for severe seizures.

The nation decriminalized growing and possessing cannabis more than 10 years ago, but buying and selling cannabis remains illegal. In 2013, Uruguay, which borders Brazil, legalized the cultivation, distribution and consumption of cannabis, which is sold in pharmacies.

End


Lawmakers Likely to Delay MMJ Implementation in North Dakota

a word from our sponsors:

advertisement

advertise here

North Dakota lawmakers are considering delaying the rollout of the state’s voter-backed medical cannabis initiative, with legislators from both sides of the aisle saying implementing the new regime takes time, according to a KFYR-TV report. If passed, parts of the medical cannabis law would not take effect until July 31.

“We want to do it right. We want to make sure that the potency is right, that the proper people can distribute, the proper people can grow, that people have access to it, and all those things take time,” Senate Minority Leader Joan Heckaman, a Democrat, said in the report.

Republican Senate Majority Leader Rich Wardner said lawmakers will “make sure” that patients get access to medical cannabis in accordance with the will of the voters, but officials need to ensure they get it “in a safe form.”

The state Department of Health is responsible for monitoring product potency and licensing growers and distributors. A bill finalizing some of those rules is expected in the coming weeks.

Sheri Paulson, one of the activists who worked on Measure 5, said she was skeptical of the move, but after testifying at a hearing dedicated to the issue, was convinced that delaying the bill will ensure the best version of the law is put forth.

“It’s not only good for the patients, but it’s also good for them, so it benefits everybody all around,” she said.

The Health Department estimates they will need at least $2.7 million over the next two years to implement the law.

End


Report: North American Cannabis Industry Could Experience 33% Annual Growth through 2021

a word from our sponsors:

advertisement

advertise here

According to a Market Research Future report, the North American cannabis market could grow at a compound annual growth rate of 33 percent through 2021, with the U.S. industry representing 95 percent market share. The North American market includes the U.S., Canada, and Mexico.

“Rapid legalizing and growing awareness about the medicinal properties of marijuana to boost the market over the forecast period,” the analysts wrote in a press release. “Marketing activities for marijuana has been primarily challenged by the consumer perception and stringent federal policies.”

In the U.S. and Mexico cannabis remains illegal on a federal level. The same applies in Canada, however it is expected that the federal government will announce a plan to legalize adult-use nationwide in the spring.

According to the analysts, some of the major key players of the North American cannabis market include the Canadian Cannabis Corporation, Plandai Biotechnology., Tweed Marijuana Inc, Affinor Growers., Cannabis Sativa Inc, Cannavest, Canna Brands Inc, Omnicanna Health Solutions., Privateer Holdings, Inc, and Arena Pharmaceuticals, Inc.

According to an ArcView Group market research report, the U.S. market last year reached $6.7 billion, a growth of 30 percent.

End


Emerald Conference Coming to San Diego Feb. 2-3

a word from our sponsors:

advertisement

advertise here

The third annual Emerald Conference, hosted by Emerald Scientific, is coming to San Diego in a few weeks.

This year’s event, which has been extended to two days and will be held February 2-3 at the Hyatt Regency Mission Bay Spa and Marina, will attract entrepreneurs from around the country and globe for two days of networking, education, and enthusiasm for cannabis science.

The Emerald Conference is one of the industry’s leading technical and scientific events, and will feature speakers such as former Ganjapreneur podcast guest Reggie Gaudino of Steep Hill, Chris Walsh of Marijuana Business Daily, and numerous other experts in scientific fields pertaining to cannabis.

Speakers and panel discussions will cover a wide variety of topics. Regarding the science of horticulture, attendees will learn about common pests and pathogens and how to deal with them, best practices for cannabis nurseries, how to manage microbial contamination in a commercial grow, and information regarding genetics/genomics in the selection and breeding processes of cannabis.

For entrepreneurs interested in the extraction and infusion fields, experts will address the best strategies for supercritical fluid processing and chemometrics in extraction. Additionally, cannabis testing lab operators can look forward to learning advanced techniques for recognizing and identifying pesticide residues, tips for terpene analysis, microbial testing best practices, and more.

The event is coordinated by Emerald Scientific, a renowned supplier of top-shelf reagents, supplies, equipment, and additional services dedicated to cannabis testing labs and other scientific endeavors in the cannabis industry.

An expansive exhibition floor will be open to conference ticket holders, offering myriad opportunities for networking and face-to-face encounters with the folks behind some of the industry’s leading scientific companies.

To purchase tickets for the Emerald Conference, see the tickets section of the event’s website.

Tickets normally cost $349 for the full event, but as a supporting partner for the event, we’re excited to announce that Ganjapreneur readers can get $50 off the regular price with the code GANJAP50, so don’t wait: purchase your tickets now to guarantee yourself a spot at this groundbreaking event.

End


New York Gov. Urges Lawmakers to Decriminalize Cannabis Possession

a word from our sponsors:

advertisement

advertise here

New York Gov. Andrew Cuomo is calling for decriminalizing cannabis in his annual State of the State address, saying that “recreational users pose little to no threat to public safety” in the state, New York Upstate reports.

“The unnecessary arrest of these individuals can have devastating economic and social effects on their lives,” the Democratic governor’s office wrote in the 383-page book.

The proposal comes after voters in Massachusetts, a New York border state, legalized cannabis for adult-use during November’s general election.

According to the report, arresting and jailing low-level cannabis possession crimes cost the state $75 million in 2019; about 90 percent of those convicted had no felonies later.

New York does have a medical cannabis program; however, it is very tightly regulated – not permitting full-plant use and allowing just five licensed operators. Recently, the state Health Department did make changes in an effort to expand the program, including adding chronic pain to the qualifying conditions list, approving physician’s assistants and nurse practitioners to write medical cannabis recommendations for patients and lifting the number of brands sold by dispensaries.

Just because the governor is pushing for reforms does not mean the legislature will heed his call. A bill would need to be authored, introduced, and passed through both houses of the legislature before heading to Cuomo for his signature.

End


Cannabis Industry Already Driving Industrial Lease Prices in Maine

a word from our sponsors:

advertisement

advertise here

The not-yet-legal cannabis industry is already driving up lease prices for industrial spaces that could be used for cultivation when the new laws take effect, according to a Portland Press Herald report. Lease prices in the Greater Portland area are already twice what they were six years ago, and local real estate brokers say that vacancy rates in the industrial sector are historically low.

“The economic opportunities for landlords are significant,” attorney Ted Kelleher of Drummond Woodsum said in the report. “Even though the process for the state granting licenses is a year away, people are already trying to secure properties.”

The medical cannabis industry has already helped to drive the low vacancy rates in the region, from 7.86 percent in 2011 to 3.38 percent in 2015. Maine cannabis growers are also more willing to pay higher rates for space – which have reached as much as $10 per square foot for the first time.

Greg Boulos of Portland’s CBRE | The Boulos Co. said the cannabis industry has “come out of the shadows,” explaining that cultivators are typically looking for properties that are 5,000 to 10,000 square feet and secluded from neighbors.

However, as the new law rolls out it’s likely that localities will choose to enact individual moratoriums and outright industry bans.

End


Indiana Veteran Pushing Lawmakers for MMJ Access

a word from our sponsors:

advertisement

advertise here

A U.S. Marines Veteran is emerging as a leading advocate for medical cannabis access in Indiana as lawmakers continue to drag their feet on the issue, according to an Indy Star report. Jeff Staker, who served in Operation Desert Storm and Operation Desert Shield, said he founded Hoosier Veterans for Medical Cannabis because “politicians listen to veterans.”

Staker, 51, was a driving force behind the Indiana American Legion’s decision to send a resolution to the state legislature calling on them to “remove restrictions from marijuana and reclassify it in a category that, at a minimum, will recognize cannabis as a drug with potential medical value.”

For the last six years a medical cannabis bill has been filed in the state legislature and for the last six years not a single one of them has even made it to a committee hearing.

The resolution by the Indiana American Legion mirrors the move by the national American Legions, calling on Congress to remove cannabis from the federal schedule.

Despite state not permitting medical cannabis use, Staker admits that he uses the drug “for medical purposes.” He has been on painkilling pharmaceuticals for at least the last 10 years and said he was interested in using cannabis after he noticed he was building a tolerance to painkillers.

“I’m the butt of jokes,” Staker said. “You know, ‘All I need is a doobie and a big bag of Doritos.’”

End


Massive Study Concludes Cannabis Has Legitimate Medicinal Value

a word from our sponsors:

advertisement

advertise here

In a sweeping study, The National Academies of Science, Engineering, and Medicine have concluded that cannabis does have legitimate medicinal value, but more research is required to determine the potential health risks, according to an Ars Technica report outlining the details.

In their 400-page analysis, researchers determined that cannabis and cannabinoids were effective in treating chronic pain and for chemotherapy-related vomiting and nausea in cancer patients, but observed that much more research is needed in order to determine the efficacy of its use as it relates to other conditions.

Additionally, the authors concluded that cannabis use is not linked to cancers attributed to smoking, but that smoking could increase respiratory problems and smoking cannabis while pregnant might lead to lower birth rates. It was not clear whether there were any long-term effects for children exposed to cannabis.

The researchers also debunked the ‘gateway’ myth associated with cannabis use, but indicated that many cannabis smokers use tobacco products and said that people who use cannabis are prone to becoming substance dependent. The committee determined that cannabis use may increase the risk of developing schizophrenia, anxiety and depression.

The committee is hopeful that the report could help steer policy discussion and concluded that cannabis should not be a Schedule I substance.

End


‘Cannabis Keurig’ Readying for April Launch

a word from our sponsors:

advertisement

advertise here

Massachusetts-based CannaKorp closed a $4.1 million Series A round of funding bringing it closer to launching its ‘cannabis Keurig’ – a single-use, pod-based vaporizer – in April, according to a BostInno report. The funding was led by cannabis investment firm Singularity Capital Management.

The company plans on first selling the CannacCloud through a network of dispensaries and processors in their home state, Rhode Island, Colorado, Washington, Oregon, and, eventually, Canada.

According to CEO and Co-Founder James Winkour, the system is expected to retail between $150 and $170. The pods are expected to run $6 to $10 depending on the strain. The products will be available at partnering dispensaries in legal U.S. states and would be available online for the Canadian market. The pods are made of recyclable aluminum in order to mitigate potential waste – a pressing sustainability concern of the traditional Keurig K-Cup.

Winker said people believe the device “helps normalize the industry” due to its design and that it would appeal to both current cannabis users who want a convenient and controlled way to consume, and those who are curious but uninterested in consuming it via traditional methods.

“We’re really focusing on ‘how do we educate the mainstream that cannabis has a beneficial effect?’” Winokur said in the report. “And that’s what we’re really after.”

End


MedMen Acquires NY MMJ Licensee Bloomfield Industries

a word from our sponsors:

advertisement

advertise here

MedMen, a California-based cannabis consulting and management firm, is acquiring New York licensed producer Bloomfield Industries, according to a Politico report. Bloomfield is one of just five companies allowed to cultivate, process, and dispense medical cannabis under the state’s limited medical cannabis program.

MedMen, who has a $100 million venture capital arm, is partnered with Wicklow Capital – the primary investor for another of the state’s five licensees, PharmaCann.

According to the report, Bloomfield had been experiencing “financial constraints” for at least six months; forced to miss vendor payments and entertain offers from investors. The company will continue to operate as “Bloomfield Industries” for the remainder of its initial two-year agreement.

Medical cannabis license transfers are not allowed under the Compassionate Care Act; however changes in ownership are permitted subject to Department of Health approval. Bloomfield is licensed to operate in New York City and grows its crop in Long Island City. They were selected to operate a dispensary in Manhattan but were never able to get it up and running.

Licensed companies in the state have long maintained that there is not enough demand due to the program’s regulatory restraints. In August, PharmaCann estimated it would be at least another 18 months before New York operators saw profitability. At that time, Etain Health and Vireo Health indicated they were in the red and Bloomfield did not return requests for comment.

Ari Hoffnung, CEO for Vireo said that Bloomfield “is a reminder” that New York’s operators “are dealing with a micro-market for medical marijuana.”

End